after the booster dose, he had Covid again/had headache, sore throat, like a mucus in his nose, stuff like that, like something in the back of his nose, and congestion.; He was feeling bad,; sore throat; like a mucus in his nose, stuff like that, like something in the back of his nose,; Congestation; Had headache; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (after the booster dose, he had Covid again/had headache, sore throat, like a mucus in his nose, stuff like that, like something in the back of his nose, and congestion.), FEELING ABNORMAL (He was feeling bad,), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (like a mucus in his nose, stuff like that, like something in the back of his nose,) and NASAL CONGESTION (Congestation) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Before his vaccination with the Moderna Covid19 Vaccine). Previously administered products included for Flu: flu shot in December 2021. Past adverse reactions to the above products included No adverse event with flu shot.   On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Dec-2021, the patient experienced COVID-19 (after the booster dose, he had Covid again/had headache, sore throat, like a mucus in his nose, stuff like that, like something in the back of his nose, and congestion.), FEELING ABNORMAL (He was feeling bad,), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (like a mucus in his nose, stuff like that, like something in the back of his nose,), NASAL CONGESTION (Congestation) and HEADACHE (Had headache). At the time of the report, COVID-19 (after the booster dose, he had Covid again/had headache, sore throat, like a mucus in his nose, stuff like that, like something in the back of his nose, and congestion.) had not resolved and FEELING ABNORMAL (He was feeling bad,), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (like a mucus in his nose, stuff like that, like something in the back of his nose,), NASAL CONGESTION (Congestation) and HEADACHE (Had headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Dec-2021, SARS-CoV-2 test: positive (Positive) Positive.    No concomitant medication was provided by the reporter.  No treatment medication was provided by the reporter. Company comment: This is a spontaneous case concerning a 35-year-old, male patient with no relevant medical history reported, who experienced the non- serious unexpected, according CCDS, AESI of COVID-19. The event occurred approximately 38 days after the third dose of mRNA-1273 vaccine. The rechallenge was not applicable. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   Patients father said that he doesn't remember when his son had covid for the first time, and thinks it was before vaccines were available and second time, he got the test on 30-DEC-2021 and had confirmation on 31-DEC-2021.  As patient was feeling bad, went for a test because he was not feeling good, had headache, sore throat, like a mucus in his nose, stuff like that, like something in the back of his nose, and congestion.  Patients father stated that his son also got the flu shot around 3 weeks ago and not taking any treatment.   This case was linked to MOD-2021-127393 (Patient Link).; Sender's Comments: This is a spontaneous case concerning a 35-year-old, male patient with no relevant medical history reported, who experienced the non- serious unexpected, according CCDS, AESI of COVID-19. The event occurred approximately 38 days after the third dose of mRNA-1273 vaccine. The rechallenge was not applicable. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.